News
The new effort will focus on cardiometabolic conditions in order to give clinicians more insights into patient care.
The company says it will begin full commercial deployment of iSTRYM in the first quarter of 2022.
The company's chief product officer wrote that deleting content as quickly as possible doesn't fix the problem.
Kintsugi says that its vocal biomarker tech can detect depression and anxiety from 20 seconds of freeform speech.
The ezOntheCall telehealth solution enables doctors to quickly retrieve patient data in real-time while conducting virtual consultations.
The company uses machine learning to detect, monitor and treat chronic and long-term health conditions.
The proposed system uses brain signals and neural patterns from children.
The new acquisition is set to give K Health more behavioral health capabilities.
The small study found nearly all patients had a complete abortion without the need for intervention.
Also: Better Therapeutics scored a $50 million loan facility, DiA Imaging Analysis raised $14 million and SCAN Group invested in MedArrive.